Core Problem Statement

Cell-based biomanufacturing continues to rely heavily on legacy, labor-intensive cell culture setups, generating high operational overheads, strict space constraints, and high batch-to-batch structural variability in biological production lines.

Solution Overview

Development of CellBRx®, a highly scalable, single-use bioreactor platform for closed-loop adherent cell cultures. The system enables fully automated and highly standardized manufacturing of vital vaccines, viral vectors, and therapeutic exosomes within compact spatial dimensions.

Strategic Engagement Opportunities

OmniBRx bioreactor platforms allow academic groups, translational research institutions, and large-scale bio-manufacturers to streamline workflow dynamics seamlessly from development phases into clinical pilot deployments.